Patients' Value of Benefits and Harms of Migraine Treatments
Publication
, Conference
Coplan, PM; Hauber, BA; Mohamed, A; Johnson, RF; Levitan, B
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
August 1, 2010
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
August 1, 2010
Volume
19
Start / End Page
S45 / S45
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Coplan, P. M., Hauber, B. A., Mohamed, A., Johnson, R. F., & Levitan, B. (2010). Patients' Value of Benefits and Harms of Migraine Treatments. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 19, pp. S45–S45). WILEY-BLACKWELL.
Coplan, Paul M., Brett A. Hauber, Ateesha Mohamed, Reed F. Johnson, and Bennett Levitan. “Patients' Value of Benefits and Harms of Migraine Treatments.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 19:S45–S45. WILEY-BLACKWELL, 2010.
Coplan PM, Hauber BA, Mohamed A, Johnson RF, Levitan B. Patients' Value of Benefits and Harms of Migraine Treatments. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL; 2010. p. S45–S45.
Coplan, Paul M., et al. “Patients' Value of Benefits and Harms of Migraine Treatments.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 19, WILEY-BLACKWELL, 2010, pp. S45–S45.
Coplan PM, Hauber BA, Mohamed A, Johnson RF, Levitan B. Patients' Value of Benefits and Harms of Migraine Treatments. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL; 2010. p. S45–S45.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
August 1, 2010
Volume
19
Start / End Page
S45 / S45
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences